BeiGene to Present New Clinical Data on Tislelizumab at ESMO IO Congress 2021

CAMBRIDGE, Mass. & BEIJING–(BUSINESS WIRE)—- $BGNE #BGNE–BeiGene will present new clinical data on tislelizumab at ESMO IO Congress 2021, including results from RATIONALE 309 in nasopharyngeal cancer.
Click here to view original post